Cabergoline
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
59762-1005 -
Package NDC
59762-1005-1 -
Application number
NDA020664 -
SPL ID
03f16695-e1cd-4d6b-9205-b3d5bf1b7c6c -
SPL set ID
e497366b-a124-4d7f-bd45-a883c392d4bb -
UNII
LL60K9J05T -
RxCUI
199703
What the source publishes
- Labeler
- Mylan Pharmaceuticals Inc.
- Active ingredients
- cabergoline
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA AUTHORIZED GENERIC
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Cabergoline",
"splId": "03f16695-e1cd-4d6b-9205-b3d5bf1b7c6c",
"labels": [
{
"setId": "e497366b-a124-4d7f-bd45-a883c392d4bb",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e497366b-a124-4d7f-bd45-a883c392d4bb",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e497366b-a124-4d7f-bd45-a883c392d4bb"
}
],
"routes": [
"ORAL"
],
"labeler": "Mylan Pharmaceuticals Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "8 TABLET in 1 BOTTLE (59762-1005-1)",
"package_ndc": "59762-1005-1",
"identifierStatus": "well-formed",
"marketing_start_date": "20140922"
}
],
"productId": "59762-1005_03f16695-e1cd-4d6b-9205-b3d5bf1b7c6c",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "59762-1005",
"deaSchedule": null,
"genericName": "cabergoline",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "CABERGOLINE",
"strength": ".5 mg/1"
}
],
"applicationNumber": "NDA020664",
"marketingCategory": "NDA AUTHORIZED GENERIC",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20140922",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"M0007652",
"N0000175827"
],
"unii": [
"LL60K9J05T"
],
"rxcui": [
"199703"
],
"spl_set_id": [
"e497366b-a124-4d7f-bd45-a883c392d4bb"
],
"pharm_class_cs": [
"Ergolines [CS]"
],
"pharm_class_epc": [
"Ergot Derivative [EPC]"
],
"manufacturer_name": [
"Mylan Pharmaceuticals Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:59762-1005_03f16695-e1cd-4d6b-9205-b3d5bf1b7c6c"